CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway–altered

Abstract Diffuse low-grade glioma, MAPK pathway–altered (DLGG–MAPK), is a recently defined tumor entity characterized by genetic alterations activating the MAPK signaling cascade. While BRAF and FGFR alterations are most frequently reported, the biological and clinical significance of other MAPK-act...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hiroaki Nagashima, Yasuhide Takeuchi, Naoe Jimbo, Hadzki Matsuda, Shiro Kimbara, Kazuhiro Tanaka, Takashi Sasayama
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2026-03-01
Colecção:	Acta Neuropathologica Communications
Assuntos:	Glioma Diffuse low-grade glioma MAPK pathway-altered CUX1 MET fusion
Acesso em linha:	https://doi.org/10.1186/s40478-026-02271-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!